Head of Engineering
About the job
- At least 8 years of experience in hardware engineering for complex electromechanical systems.
- Deep proficiency in computer-aided design (CAD), tolerances, prototyping, and manufacturing.
- Experience owning the product lifecycle from concept through transfer and scale-up.
- Ability to build and manage technical teams.
- Systems-level troubleshooting expertise across mechanical, fluidic, and electronic systems.
- Own the GutLab architecture, including electromechanical and fluidic systems, and lead design, testing, and refinement through computer-aided design, prototyping, and manufacturing.
- Own validation, stage gates, documentation, and traceability across revisions, firmware, and field performance; lead troubleshooting, diagnostics, and closed-loop fixes to eliminate systemic failure modes.
- Set and execute high standards for all hardware development, including procurement, transfer, sustaining engineering, and operations.
- Drive design for manufacturing, design freeze, pilot builds, supplier alignment, cost targets, and manufacturing strategy and execution for Gen3.
- Mentor and lead a hardware team; align resources, timelines, and execution to production milestones.
- Address procurement challenges and identify cost-effective solutions.
- Partner with other leaders to align hardware development with broader company strategy and goals.
About the company
BiomeSense provides an integrated platform for gut microbiome analysis, combining an at-home biosensor for continuous monitoring with a cloud-based, AI-powered data analysis system. Users collect longitudinal microbiome data at home, which is securely transmitted to the cloud where AI algorithms identify patterns and track changes over time. The company differentiates itself by offering a low-cost, large-scale hardware-and-software solution designed for clinical trials and consumer health, rather than relying on single-time-point tests. Its goal is to help researchers and product teams use microbiome data to understand health and disease and advance precision medicine.
Company Size
11-50
Company Stage
Seed
Total Funding
$5.4M
Headquarters
Chicago, Illinois
Founded
2018
Get referred to BiomeSense
See people who can refer or advise you
Simplify's Take
What believers are saying
- BiomeSense won a $676,980 NIH SBIR/STTR award in June 2026.
- The October 2025 $7M round added Labcorp Venture Fund and Bluestein Ventures.
- Updated August 2026 website shows active product development and partner messaging.
What critics are saying
- The 2024 Pendulum pilot enrolled only 15 people, proving science, not revenue.
- BiomeSense still lacks broad commercial traction; 2026 evidence shows grants, not scaled contracts.
- If GutLab adoption stalls, larger microbiome platforms and simple sequencing workflows outcompete BiomeSense.
What makes BiomeSense unique
- GutLab and MetaBiome target continuous, longitudinal microbiome data, not single stool snapshots.
- BiomeSense claims 30x more data and up to 90% per-sample cost reduction.
- Pendulum’s 2024 pilot validated home-based serial sampling with BiomeSense's GutLab.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Stock Options
- Paid Vacation
- Parental Leave